as on November 7, 2025 at 12:33 am IST
Day's Low
Day's High
2.87%
Downside
6.05%
Upside
52 Week's Low
52 Week's High
62.90%
Downside
8.12%
Upside
Check Insight Molecular Diagnostics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$86.7M
EPS (TTM)
-0.99
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-428.96%
Compare market cap, revenue, PE, and other key metrics of Insight Molecular Diagnostics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $86.7M | NA | NA | 0.00% | |
| BUY | $57.8B | 50.64% | 57.4 | 24.65% | |
| BUY | $212.4B | 7.58% | 32.67 | 15.02% | |
| BUY | $41.4B | 30.42% | 34.13 | 17.97% | |
| BUY | $35.8B | 22.56% | 28.86 | 8.07% |
Search interest for Insight Molecular Diagnostics Inc Stock has increased by 450% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:450% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, IMDX has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 1 month, IMDX stock has moved up by 103.0%
Against Peers
![]()
In the last 3 years, Idexx Laboratories, Inc. has given 93.7% return, outperforming this stock by 143.4%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 2.13M → 518.0K (in $), with an average decrease of 75.8% per quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, -6.67M → -9.74M (in $), with an average decrease of 46.0% per quarter
| Organisation | Insight Molecular Diagnostics Inc |
| Headquarters | 2 International Plaza Dr., Nashville, TN, United States, 37217 |
| CEO | Mr. Joshua Riggs |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Peter Hong | VP, General Counsel & Secretary |
Ms. Sandra O'Donald | Senior Vice President of Business Operations |
Dr. Michael D. West Ph.D. | Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc. |
Ms. Andrea Susan James | Chief Financial Officer |
Mr. James Liu | VP of Accounting, Treasurer, Controller & Principal Accounting Officer |
Dr. Ekkehard Schutz M.D., Ph.D. | Chief Science Officer |
Ms. Gabrielle Woody | Sr. Executive Assistant |
Mr. Joshua Riggs | President, CEO & Director |
Mr. Yuh-Min Chiang Ph.D. | Chief Technology Officer |
Dr. Paul R. Billings FACP, M.D., Ph.D. | Consulting Chief Medical Officer |
Insight Molecular Diagnostics Inc share price today is $6.28 as on . Insight Molecular Diagnostics Inc share today touched a day high of $6.66 and a low of $6.1.
Insight Molecular Diagnostics Inc share touched a 52 week high of $6.79 on and a 52 week low of $2.33 on . Insight Molecular Diagnostics Inc stock price today i.e. is trending at $6.28,which is 7.51% down from its 52 week high and 169.53% up from its 52 week low.
Insight Molecular Diagnostics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Insight Molecular Diagnostics Inc (IMDX) shares with as little as ₹88.566 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹885.66 in Insight Molecular Diagnostics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Insight Molecular Diagnostics Inc share’s latest price of $6.28 as on November 7, 2025 at 12:33 am IST, you will get 1.5924 shares of Insight Molecular Diagnostics Inc. Learn more about
fractional shares .